Related Experiment Video

Updated: May 26, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Association of Janus kinase 2 (JAK2) polymorphisms with acute leukemia susceptibility

Y Zhong1, J Wu, R Ma

  • 1Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.

International Journal of Laboratory Hematology
|December 16, 2011
PubMed
Abstract

Insights

Genetic variations in the Janus kinase 2 (JAK2) gene are linked to an increased risk of developing acute leukemia. Specifically, the rs2230724 polymorphism is identified as a significant genetic determinant for this cancer.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Aberrant Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway signaling drives uncontrolled cell proliferation, differentiation, and apoptosis.
  • The JAK2 gene is crucial for metabolizing carcinogens and medications.
  • Genetic variations may influence individual susceptibility to diseases like cancer.

Purpose of the Study:

  • To investigate the association between genetic polymorphisms in the JAK2 gene and the risk of acute leukemia.
  • To identify specific JAK2 gene variants that may confer susceptibility to acute leukemia in a Chinese population.

Main Methods:

  • A case-control study was conducted involving 260 acute leukemia patients and 280 healthy controls from a Chinese population.
  • Genomic DNA was analyzed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF).
  • Five genetic polymorphisms within the JAK2 gene were examined.

Main Results:

  • The rs56118985 GA genotype showed a slight difference in distribution between acute leukemia patients and controls (P = 0.049).
  • Frequencies of rs2230724 AA and GA genotypes were significantly higher in acute leukemia patients compared to controls (P < 0.001).
  • The A allele of rs2230724 was identified as a significant genetic determinant for acute leukemia and acute myeloid leukemia (AML).

Conclusions:

  • Genetic polymorphisms in the JAK2 gene are associated with an increased risk of acute leukemia.
  • The rs2230724 polymorphism in the JAK2 gene is a potential genetic marker for acute leukemia susceptibility.

More Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...